Hansa Biopharma AB
STO:HNSA
Hansa Biopharma AB
STO:HNSA
Price:
28.68
SEK
-3.43%
Market Closed
Market Cap:
kr2.9B
Wall Street
Price Targets
HNSA Price Targets Summary
Hansa Biopharma AB
Hansa Biopharma AB
Wall Street analysts forecast HNSA stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
HNSA
is 77.78 SEK
with a low forecast of 35.35 SEK and a high forecast of 108.15 SEK.
Lowest
Price Target
35.35
SEK
23% Upside
Average
Price Target
77.78
SEK
171% Upside
Highest
Price Target
108.15
SEK
277% Upside
Hansa Biopharma AB Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HNSA's stock price target?
Price Target
77.78
SEK
77.78
SEK
According to Wall Street analysts, the average 1-year price target for
HNSA
is 77.78 SEK
with a low forecast of 35.35 SEK and a high forecast of 108.15 SEK.
What is Hansa Biopharma AB's Revenue forecast?
Projected CAGR
76%
76%
For the last 14 years the
compound annual growth rate for
Hansa Biopharma AB's revenue is
44%.
The projected
CAGR
for the next 3 years is
76%.
